Curis reports $8.1 million net loss for Q3 2026 and clinical data
CRIS Curis Inc
$0.44 -22.18%
View chart & analysis → - 1Curis recorded a net loss of $8.1 million for Q3 2026, representing a net loss of $1.94 per share.
- 2Curis reported an 86% response rate among 7 BTK-naive patients in Q3 2026.
- 3Curis confirmed a 26% response rate among 39 salvage-line patients in Q3 2026.
So what's the key point?
Curis reported a loss of $8.1 million in the third quarter of 2026. The company also confirmed response rates from its clinical treatments for patients.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.